Beloteca, Inc. is focused on the development of pharmaceutical products with an emphasis on sterile pharmaceutical products. The primary products in their pipeline are generic drug products and 505(b)(2) reformulations of existing products covering a wide range of therapeutic areas. They target niche or difficult to manufacture products.
$1 mil - $10 mil
50 - 100